Monday, 20 July 2026 · World
USD/EUR 0.875 USD/GBP 0.7439 USD/JPY 162.5 USD/CNY 6.781 All rates →
RSS
EUROS The World Financial Report
Nº 9 Monday, 20 July 2026 · World Edition
LATEST
Front Page

Oklo stock slides 42% despite $87 median analyst target

EUROS Newsroom · 18h ago · 1 min read
Oklo stock slides 42% despite $87 median analyst target

Oklo shares have dropped sharply this year, but a massive cash pile and bullish analyst targets highlight a major disconnect between the company's current pre-revenue status and its long-term nuclear ambitions.

Oklo stock has fallen more than 42% in 2026. Yet, Wall Street analysts remain overwhelmingly bullish on the pre-revenue nuclear energy developer.

The company's shares closed at $41.11 on July 16. Despite this slump, the median one-year price target among 22 tracked analysts stands at $87, suggesting a potential return of roughly 112% from current levels. The most optimistic forecast on the board is $140, which implies an upside exceeding 240%.

For market participants, the stark divergence between the stock's recent price action and these elevated projections highlights the speculative nature of valuing advanced nuclear ventures. Oklo has yet to commence commercial operations. Until its reactors are fully operational, there is no revenue baseline for traditional valuation metrics.

The underlying investment thesis relies on Oklo's highly integrated business model. The company intends to fabricate its own fuel, power its reactors, and sell both heat and electricity directly to end users. Additionally, its proposed recycling technology aims to establish a continuous fuel cycle, differentiating Oklo from standard utilities if successfully scaled.

Capital Position

While the path to commercial power generation involves significant regulatory and construction hurdles, Oklo's balance sheet removes near-term liquidity risks. The business held $2.5 billion in cash and marketable securities as of March 31. This substantial capital provides a multi-year runway to execute its development roadmap without facing the funding constraints that often plague early-stage industrial companies.

Even with a fortified balance sheet, some market observers caution that the $87 median target may be difficult to reach within the next 12 months. Because the company cannot yet generate meaningful revenue, investors buying at current prices are essentially betting on future regulatory tailwinds and construction milestones. A more balanced risk-to-reward scenario requires extending that price horizon by several years to align with the reality of bringing a new nuclear platform online.